Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 376, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
STAG2 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chrX:124062973-124062985 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNDC3A hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr13:49203211-49203237 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLF5 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.492
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr13:73062301-73062323 PAR-CLIP POSITIVE DIRECT TarBase 7.0
KATNAL1 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.643
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr13:30206493-30206517 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NFAT5 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr16:69703537-69703557 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CTCF hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr16:67611966-67611987 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CYB5B hsa-miR-582-3p low: 0 high: 1 1 1 1 0.658
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:69462609-69462621 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NME4 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:400428-400440 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC7A5 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr16:87830099-87830125 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PIEZO1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr16:88734701-88734723 PAR-CLIP POSITIVE DIRECT TarBase 7.0
BMF hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr15:40090271-40090281 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ESRP1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr8:94706178-94706204 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EEF1D hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:143587458-143587486 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BABAM1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr19:17276575-17276602 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GTPBP10 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:90384961-90384972 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.561
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:92609686-92609706 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SP4 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:21513678-21513700 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CBLL1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:107758983-107758997 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HOXA1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:27093440-27093453 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TMEM106B hsa-miR-582-3p low: 0 high: 1 1 1 1 0.628
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:12232827-12232849 HITS-CLIP POSITIVE DIRECT TarBase 7.0